Calmare Therapeutics (CTTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 01-2000 | 12-1999 | 09-1999 | 07-1999 | 06-1999 | |
| Sales | 1,146 | 1,146 | 571 | 0 | 1,034 |
| Cost of Goods | 512 | 560 | 560 | N/A | 510 |
| Gross Profit | 634 | 7 | 7 | N/A | 670 |
| Operating Expenses | 864 | 780 | 780 | 0 | 750 |
| Operating Income | 282 | 366 | -209 | N/A | 284 |
| Other Income | 147 | -506 | 69 | 0 | 166 |
| Pre-tax Income | 429 | -140 | -140 | 0 | 450 |
| Income Tax | N/A | 0 | 0 | N/A | 50 |
| Net Income Continuous | 429 | 429 | -141 | N/A | 2,587 |
| Net Income | $429 | $429 | $-141 | $N/A | $2,587 |
| EPS Basic Total Ops | 0.07 | 0.07 | -0.02 | N/A | 0.43 |
| EPS Basic Continuous Ops | 0.07 | 0.07 | -0.02 | N/A | 0.43 |
| EPS Diluted Total Ops | 0.07 | 0.07 | -0.02 | N/A | 0.43 |
| EPS Diluted Continuous Ops | 0.07 | 0.07 | -0.02 | N/A | 0.43 |
| EBITDA(a) | $386 | $216 | $-159 | $N/A | $334 |